Last edition
News about "RNA interference"
AviadoBio Broadens vMiX Platform Agreement with King's College London
AviadoBio has expanded its exclusive vMiX Precision Gene Silencing Platform agreement with King’s College London to cover all human therapeutic areas. Backed by positive AVB-406 preclinical data, the RNAi-based platform highlights broad potential for targeted gene therapies.
RNA Interference | 17/06/2026 | By News Bureau
Next-generation Nanomedicine can Silence Key Cancer Drivers: Research
Scientists in Pune have developed a next-generation precision nanomedicine that uses gene-silencing technology to target key cancer drivers and effectively inhibit breast tumor growth, highlighting a promising new approach for targeted breast cancer treatment and precision oncology.
RNA Interference | 04/06/2026 | By News Bureau | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy